Charme Capital Partners

Private Equity Lombardy, Italy ·Founded 2003

Overview

Charme Capital Partners is a European mid-market private equity firm, supporting management teams and shareholders to achieve transformational change, growth, and internationalisation. With offices in Milan, London, and Madrid, the firm invests in businesses across Europe with an enterprise value of €100 million to €500 million. Since its inception in 2003, Charme Capital Partners has raised approximately €2 billion across four funds, focusing on long-term industrial investments in companies with strong growth and internationalisation prospects. The firm's portfolio includes investments in various sectors, such as consumer goods, technology, healthcare, industrial goods, financial services, media, education, energy, transportation, telecommunications, retail, real estate, leisure, food and beverage, and pharmaceuticals. Charme Capital Partners is known for its responsible ownership approach, aiming to enhance the value of its portfolio companies through operational support, capital, and strategic vision. The firm's investment strategy emphasizes long-term relationships, proprietary deal sourcing, and a strong entrepreneurial culture, enabling portfolio companies to expand internationally throughout economic cycles. Charme Capital Partners' investor base comprises prominent global families, industrialists, and institutional limited partners, reflecting its commitment to delivering consistent returns and supporting the growth of its portfolio companies. The firm's funds have been involved in notable investments, including the Poltrona Frau Group, Octo Telematics, Bellco, ATOP, Fiocchi, OCS, Igenomix, Witherslack, Bianalisi, Indiba, Prism Healthcare, and Tema Sinergie, among others. Charme Capital Partners continues to seek investment opportunities in companies with strong market leadership and growth potential, aiming to create value through strategic partnerships and operational improvements. The firm's approach combines institutional expertise with entrepreneurial insight, fostering a collaborative environment that drives sustainable growth and value creation for its portfolio companies and investors.

Investment Focus

  • Companies with enterprise values between €100 million and €500 million
  • Strong market leadership
  • Growth potential
  • Opportunities for internationalisation

Portfolio Companies

BianalisiPoltrona Frau GroupOcto TelematicsBellcoATOPFiocchiOCSIgenomixWitherslackIndibaPrism HealthcareTema Sinergie

Get the full list of 54,000+ investors

Charme Capital Partners and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Charme Capital Partners

What sectors does Charme Capital Partners invest in?

Charme Capital Partners invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Lombardy, Italy. Charme Capital Partners is listed as a private equity in the ConnectSafely investor database.

What stage does Charme Capital Partners invest at?

Charme Capital Partners backs companies at Growth and Buyout, writing cheques of 100M - 500M.

Which regions does Charme Capital Partners invest in?

Charme Capital Partners invests across United Kingdom, Italy and Spain.

What companies has Charme Capital Partners invested in?

Charme Capital Partners's portfolio includes Bianalisi, Poltrona Frau Group, Octo Telematics, Bellco, ATOP, Fiocchi, OCS and Igenomix.

Last updated · Source: ConnectSafely investor database